Oncotelic Therapeutics, Inc.
OTLC· OTC
Filed Apr 17, 2018 · 10-K · 107 days after period end · 0001193125-18-119206
derived · Computed from the longer spans the company filed.
| Metric | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$2.43M | -$3.45M | — | -$2.64M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Apr 17, 2018 · 107 d after period end